Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic association of IL2RA, IL17RA, IL23R, and IL31RA single nucleotide polymorphisms with alopecia areata. | Saudi J Biol Sci | 2022 | 36248775 | PubTator, text mining | PubMed |
| Cytokine Modulators in Plaque Psoriasis - A Review of Current and Prospective Biologic Therapeutic Approaches. | JAAD Int | 2022 | 36248203 | PubTator, text mining | PubMed |
| Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris. | Clin Case Rep | 2022 | 36245447 | PubTator, text mining | PubMed |
| CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma. | Front Immunol | 2022 | 36238304 | PubTator, text mining | PubMed |
| Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Int J Mol Sci | 2022 | 36233152 | PubTator, text mining | PubMed |
| The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use. | Int J Mol Sci | 2022 | 36232832 | PubTator, text mining | PubMed |
| Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives. | Int J Mol Sci | 2022 | 36232430 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing combined with whole exome sequencing reveals the landscape of the immune pathogenic response to chronic mucocutaneous candidiasis with STAT1 GOF mutation. | Front Immunol | 2022 | 36225936 | PubTator, text mining | PubMed |
| Murine Models of Chronic Viral Infections and Associated Cancers. | Mol Biol | 2022 | 36217336 | PubTator, text mining | PubMed |
| The global landscape of approved antibody therapies. | Antib Ther | 2022 | 36213257 | PubTator, text mining | PubMed |
| Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target. | Front Immunol | 2022 | 36211343 | PubTator, text mining | PubMed |
| Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis. | Dermatol Ther (Heidelb) | 2022 | 36208408 | PubTator, text mining | PubMed |
| RNA-seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy. | Microcirculation | 2022 | 36198058 | PubTator, text mining | PubMed |
| Immune and pathophysiologic profiling of antenatal coronavirus disease 2019 in the GIFT cohort: A Singaporean case-control study. | Front Pediatr | 2022 | 36186648 | PubTator, text mining | PubMed |
| Early IL-17A Prevention Rather Than Late IL-17A Neutralization Attenuates Toluene Diisocyanate-Induced Mixed Granulocytic Asthma. | Allergy Asthma Immunol Res | 2022 | 36174994 | PubTator, text mining | PubMed |
| L36G is associated with cutaneous antiviral competence in psoriasis. | Front Immunol | 2022 | 36172384 | PubTator, text mining | PubMed |
| Identification of diagnostic mRNA biomarkers in whole blood for ankylosing spondylitis using WGCNA and machine learning feature selection. | Front Immunol | 2022 | 36172367 | PubTator, text mining | PubMed |
| FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA. | Front Oncol | 2022 | 36172147 | PubTator, text mining | PubMed |
| The viral and inflammation hypothesis of epileptic seizures based on bioinformatic study of circulating miRNAs and peripheral whole-blood mRNAs of adult epilepsy patients. | Front Neurol | 2022 | 36172025 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2. | EMBO Rep | 2022 | 36161689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=45